DILH
VRTX icon

Dai-ichi Life Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Dai-ichi Life Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-39,309
Closed -$3.43M – 438
2016
Q3 		$3.43M Buy
39,309
+3,799
+11% +$359K 0.1% 214
2016
Q2 		$3.06M Buy
35,510
+8,829
+33% +$763K 0.09% 242
2016
Q1 		$2.12M Sell
26,681
-8,444
-24% -$764K 0.06% 295
2015
Q4 		$4.42M Sell
35,125
-953
-3% -$115K 0.14% 170
2015
Q3 		$3.76M Sell
36,078
-3,342
-8% -$429K 0.12% 182
2015
Q2 		$4.87M Sell
39,420
-5,275
-12% -$665K 0.15% 155
2015
Q1 		$5.27M Buy
44,695
+15,063
+51% +$1.8M 0.15% 159
2014
Q4 		$3.52M Sell
29,632
-232
-0.8% -$26.1K 0.1% 213
2014
Q3 		$3.35M Buy
29,864
+16,928
+131% +$1.61M 0.1% 205
2014
Q2 		$1.23M Buy
12,936
+539
+4% +$37.8K 0.04% 381
2014
Q1 		$877K Sell
12,397
-24,562
-66% -$1.95M 0.03% 396
2013
Q4 		$2.75M Sell
36,959
-759
-2% -$52.9K 0.08% 251
2013
Q3 		$2.86M Buy
37,718
+32,011
+561% +$2.55M 0.1% 214
2013
Q2 		$456K Buy
+5,707
New +$420K 0.02% 428

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dai-ichi Life Holdings's VRTX Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Vertex Pharmaceuticals (VRTX) in Q4 2016, closing a stake of 39,309 shares — an estimated $3.43M sold.

Dai-ichi Life Holdings first reported a position in VRTX in Q2 2013 and held it in 14 quarters. The position peaked at $5.27M in Q1 2015. 483 funds tracked by Wall St. Rank hold VRTX as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Vertex Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 39,309 Vertex Pharmaceuticals shares in Q4 2016, an estimated $3.43M.
  • Dai-ichi Life Holdings first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Dai-ichi Life Holdings's Vertex Pharmaceuticals position peaked at $5.27M in Q1 2015.
  • 483 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.